{
  "DOI": "10.1186/s40246-023-00531-2",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00531-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eRUNX1 is a transcription factor and a master regulator for the specification of the hematopoietic lineage during embryogenesis and postnatal megakaryopoiesis. Mutations and rearrangements on \u003cjats:italic\u003eRUNX1\u003c/jats:italic\u003e are key drivers of hematological malignancies. In humans, this gene is localized to the ‘Down syndrome critical region’ of chromosome 21, triplication of which is necessary and sufficient for most phenotypes that characterize Trisomy 21.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMain body\u003c/jats:title\u003e\n                \u003cjats:p\u003eIndividuals with Down syndrome show a higher predisposition to leukemias. Hence, RUNX1 overexpression was initially proposed as a critical player on Down syndrome-associated leukemogenesis. Less is known about the functions of RUNX1 in other tissues and organs, although growing reports show important implications in development or homeostasis of neural tissues, muscle, heart, bone, ovary, or the endothelium, among others. Even less is understood about the consequences on these tissues of RUNX1 gene dosage alterations in the context of Down syndrome. In this review, we summarize the current knowledge on RUNX1 activities outside blood/leukemia, while suggesting for the first time their potential relation to specific Trisomy 21 co-occurring conditions.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur concise review on the emerging RUNX1 roles in different tissues outside the hematopoietic context provides a number of well-funded hypotheses that will open new research avenues toward a better understanding of RUNX1-mediated transcription in health and disease, contributing to novel potential diagnostic and therapeutic strategies for Down syndrome-associated conditions.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "531"
  ],
  "article-number": "83",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "13 July 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "29 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 September 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Rozen",
      "given": "Esteban J.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ozeroff",
      "given": "Christopher D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Allen",
      "given": "Mary Ann",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        9,
        5
      ]
    ],
    "date-time": "2023-09-05T12:02:31Z",
    "timestamp": 1693915351000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        17
      ]
    ],
    "date-time": "2023-11-17T13:41:57Z",
    "timestamp": 1700228517000
  },
  "funder": [
    {
      "DOI": "10.13039/100020120",
      "doi-asserted-by": "publisher",
      "name": "Anna and John J. Sie Foundation"
    },
    {
      "DOI": "10.13039/100000002",
      "award": [
        "1R01HL156475-01",
        "1R01HL156475-01"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Institutes of Health"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        12,
        27
      ]
    ],
    "date-time": "2023-12-27T06:59:35Z",
    "timestamp": 1703660375063
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        9,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            5
          ]
        ],
        "date-time": "2023-09-05T00:00:00Z",
        "timestamp": 1693872000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            5
          ]
        ],
        "date-time": "2023-09-05T00:00:00Z",
        "timestamp": 1693872000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00531-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00531-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00531-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        9,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        9,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1242/dev.148296",
      "author": "R Mevel",
      "doi-asserted-by": "publisher",
      "journal-title": "Development",
      "key": "531_CR1",
      "unstructured": "Mevel R, Draper JE, Lie-A-Ling M, Kouskoff V, Lacaud G. RUNX transcription factors: Orchestrators of development. Development. 2019. https://doi.org/10.1242/dev.148296.",
      "year": "2019"
    },
    {
      "DOI": "10.1038/sj.onc.1207670",
      "author": "D Levanon",
      "doi-asserted-by": "publisher",
      "journal-title": "Oncogene",
      "key": "531_CR2",
      "unstructured": "Levanon D, Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004. https://doi.org/10.1038/sj.onc.1207670.",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1471-2148-3-4",
      "author": "J Rennert",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "issue": "1",
      "journal-title": "BMC Evolut Biol",
      "key": "531_CR3",
      "unstructured": "Rennert J, Coffman JA, Mushegian AR, Robertson AJ. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evolut Biol. 2003;3(1):4. https://doi.org/10.1186/1471-2148-3-4.",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.1128/jvi.64.10.4808-4819.1990",
      "author": "Y Kamachi",
      "doi-asserted-by": "publisher",
      "journal-title": "J Virol",
      "key": "531_CR4",
      "unstructured": "Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol. 1990. https://doi.org/10.1128/jvi.64.10.4808-4819.1990.",
      "year": "1990"
    },
    {
      "DOI": "10.1128/MCB.12.1.89",
      "author": "SW Wang",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cell Biol",
      "key": "531_CR5",
      "unstructured": "Wang SW, Speck NA. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol. 1992. https://doi.org/10.1128/MCB.12.1.89.",
      "year": "1992"
    },
    {
      "DOI": "10.1242/dev.140970",
      "author": "AJ Lilly",
      "doi-asserted-by": "publisher",
      "journal-title": "Development",
      "key": "531_CR6",
      "unstructured": "Lilly AJ, Costa G, Largeot A, Fadlullah MZH, Lie-A-Ling M, Lacaud G, et al. Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac. Development. 2016. https://doi.org/10.1242/dev.140970.",
      "year": "2016"
    },
    {
      "DOI": "10.1038/10658",
      "author": "T Nagata",
      "doi-asserted-by": "crossref",
      "first-page": "615",
      "issue": "7",
      "journal-title": "Nat Struct Biol",
      "key": "531_CR7",
      "unstructured": "Nagata T, Gupta V, Sorce D, Kim WY, Sali A, Chait BT, et al. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. Nat Struct Biol. 1999;6(7):615–9.",
      "volume": "6",
      "year": "1999"
    },
    {
      "DOI": "10.1182/blood.V99.4.1364",
      "author": "J Michaud",
      "doi-asserted-by": "publisher",
      "journal-title": "Blood",
      "key": "531_CR8",
      "unstructured": "Michaud J, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood. 2002. https://doi.org/10.1182/blood.V99.4.1364.",
      "year": "2002"
    },
    {
      "DOI": "10.4049/jimmunol.172.7.4359",
      "author": "JC Telfer",
      "doi-asserted-by": "publisher",
      "journal-title": "J Immunol",
      "key": "531_CR9",
      "unstructured": "Telfer JC, Hedblom EE, Anderson MK, Laurent MN, Rothenberg EV. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J Immunol. 2004. https://doi.org/10.4049/jimmunol.172.7.4359.",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.95.20.11590",
      "doi-asserted-by": "crossref",
      "key": "531_CR10",
      "unstructured": "Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, et al. Transcriptional repression by AML1 and LEF-1 is mediated by the TLEGroucho corepressors [Internet]. Vol. 95, Biochemistry Communicated by Leo Sachs. 1998. Available from: www.pnas.org."
    },
    {
      "DOI": "10.1038/icb.2012.6",
      "author": "W Seo",
      "doi-asserted-by": "publisher",
      "journal-title": "Immunol Cell Biol",
      "key": "531_CR11",
      "unstructured": "Seo W, Tanaka H, Miyamoto C, Levanon D, Groner Y, Taniuchi I. Roles of VWRPY motif-mediated gene repression by Runx proteins during T-cell development. Immunol Cell Biol. 2012. https://doi.org/10.1038/icb.2012.6.",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.0602470103",
      "author": "M Yarmus",
      "doi-asserted-by": "publisher",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "531_CR12",
      "unstructured": "Yarmus M, Woolf E, Bernstein Y, Fainaru O, Negreanu V, Levanon D, et al. Groucho/transducin-like enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3. Proc Natl Acad Sci U S A. 2006. https://doi.org/10.1073/pnas.0602470103.",
      "year": "2006"
    },
    {
      "key": "531_CR13",
      "unstructured": "Bravo J, Li Z, Speck NA, Warren AJ. The leukemia-associated AML1 (Runx1)-CBFβ complex functions as a DNA-induced molecular clamp [Internet]. 2001. Available from: http://structbio.nature.com."
    },
    {
      "DOI": "10.1093/emboj/20.4.723",
      "author": "G Huang",
      "doi-asserted-by": "publisher",
      "journal-title": "EMBO J",
      "key": "531_CR14",
      "unstructured": "Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y. Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 2001. https://doi.org/10.1093/emboj/20.4.723.",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0014-5793",
      "author": "YY Tang",
      "doi-asserted-by": "publisher",
      "journal-title": "FEBS Lett",
      "key": "531_CR15",
      "unstructured": "Tang YY, Crute BE, Iii JJK, Huang X, Yan J, Shi J, et al. Biophysical characterization of interactions between the core binding factor K and L subunits and DNA. FEBS Lett. 2000. https://doi.org/10.1016/S0014-5793.",
      "year": "2000"
    },
    {
      "DOI": "10.1038/nsmb819",
      "doi-asserted-by": "crossref",
      "key": "531_CR16",
      "unstructured": "Yan J, Liu Y, Lukasik SM, Speck NA, Bushweller JH. A R T I C L E S CBFβ allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium Core binding factors (CBFs) are heterodimeric transcription factors consisting of a DNA-binding CBF subunit and non-DNA-binding CBF subunit. The CBF subunit increases the affinity of the DNA-binding Runt domain of CBF for DNA while making no direct contacts to the DNA. We present evidence for conformational exchange in the. Nat Struct Mol Biol [Internet]. 2004;11(9). Available from: http://www.nature.com/natstructmolbiol."
    },
    {
      "key": "531_CR17",
      "unstructured": "Wang CQ, Mok MMH, Yokomizo T, Tergaonkar V, Osato M. RUNX Proteins in Development and Cancer. Vol. 962, Advances in Experimental Medicine and Biology. 2017."
    },
    {
      "DOI": "10.1093/nar/23.14.2762",
      "author": "H Miyoshi",
      "doi-asserted-by": "crossref",
      "first-page": "2762",
      "issue": "14",
      "journal-title": "Nucleic Acids Res",
      "key": "531_CR18",
      "unstructured": "Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 1995;23(14):2762–9.",
      "volume": "23",
      "year": "1995"
    },
    {
      "DOI": "10.1182/blood-2013-08-521252",
      "author": "Y Komeno",
      "doi-asserted-by": "crossref",
      "first-page": "3760",
      "issue": "24",
      "journal-title": "Blood",
      "key": "531_CR19",
      "unstructured": "Komeno Y, Yan M, Matsuura S, Lam K, Lo MC, Huang YJ, et al. Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice. Blood. 2014;123(24):3760–9.",
      "volume": "123",
      "year": "2014"
    },
    {
      "DOI": "10.1182/blood.2022017619",
      "doi-asserted-by": "crossref",
      "key": "531_CR20",
      "unstructured": "Gialesaki S, Bräuer-Hartmann D, Issa H, Bhayadia R, Alejo-Valle O, Verboon L, et al. RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia. Blood. 2023;141(10)."
    },
    {
      "DOI": "10.1002/j.1460-2075.1995.tb07008.x",
      "author": "T Tanaka",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "issue": "2",
      "journal-title": "EMBO J",
      "key": "531_CR21",
      "unstructured": "Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, et al. An acute myeloid leukemia gene, AML 1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J. 1995;14(2):341–50.",
      "volume": "14",
      "year": "1995"
    },
    {
      "DOI": "10.1371/journal.pmed.0040172",
      "author": "S Tsuzuki",
      "doi-asserted-by": "crossref",
      "first-page": "0880",
      "issue": "5",
      "journal-title": "PLoS Med",
      "key": "531_CR22",
      "unstructured": "Tsuzuki S, Hong D, Gupta R, Matsuo K, Seto M, Enver T. Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med. 2007;4(5):0880–96.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1182/blood-2011-06-362277",
      "author": "S Tsuzuki",
      "doi-asserted-by": "crossref",
      "first-page": "727",
      "issue": "3",
      "journal-title": "Blood",
      "key": "531_CR23",
      "unstructured": "Tsuzuki S, Seto M. Expansion of functionally defined mouse hematopoietic stem and progenitor cells by a short isoform of RUNX1/AML1. Blood. 2012;119(3):727–35.",
      "volume": "119",
      "year": "2012"
    },
    {
      "DOI": "10.1038/leu.2008.350",
      "author": "X Liu",
      "doi-asserted-by": "crossref",
      "first-page": "739",
      "issue": "4",
      "journal-title": "Leukemia",
      "key": "531_CR24",
      "unstructured": "Liu X, Zhang Q, Zhang DE, Zhou C, Xing H, Tian Z, et al. Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis. Leukemia. 2009;23(4):739–45.",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2011-12-397091",
      "author": "H Guo",
      "doi-asserted-by": "crossref",
      "first-page": "4408",
      "issue": "19",
      "journal-title": "Blood",
      "key": "531_CR25",
      "unstructured": "Guo H, Ma O, Speck NA, Friedman AD. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis. Blood. 2012;119(19):4408–18.",
      "volume": "119",
      "year": "2012"
    },
    {
      "DOI": "10.1182/blood-2012-08-451641",
      "doi-asserted-by": "crossref",
      "key": "531_CR26",
      "unstructured": "Ran D, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, et al. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. 2013; Available from: http://ashpublications.org/blood/article-pdf/121/15/2882/1365983/2882.pdf."
    },
    {
      "DOI": "10.1016/j.exphem.2015.06.245",
      "doi-asserted-by": "crossref",
      "key": "531_CR27",
      "unstructured": "Sakurai H, Harada Y, Matsui H, Nakajima H, Kitamura T, Komatsu N, et al. Overexpression of RUNX1 short isoform plays a pivotal role in the development of myelodysplastic syndromes/myeloproliferative neoplasms. Exp Hematol. 2015;43(9)."
    },
    {
      "DOI": "10.1182/bloodadvances.2016002725",
      "author": "H Sakurai",
      "doi-asserted-by": "crossref",
      "first-page": "1382",
      "issue": "18",
      "journal-title": "Blood Adv",
      "key": "531_CR28",
      "unstructured": "Sakurai H, Harada Y, Ogata Y, Kagiyama Y, Shingai N, Doki N, et al. Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms. Blood Adv. 2017;1(18):1382–6.",
      "volume": "1",
      "year": "2017"
    },
    {
      "DOI": "10.3109/03009730903572065",
      "author": "N Kanaykina",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "issue": "1",
      "journal-title": "Ups J Med Sci",
      "key": "531_CR29",
      "unstructured": "Kanaykina N, Abelson K, King D, Liakhovitskaia A, Schreiner S, Wegner M, et al. In vitro and in vivo effects on neural crest stem cell differentiation by conditional activation of Runx1 short isoform and its effect on neuropathic pain behavior. Ups J Med Sci. 2010;115(1):56–64.",
      "volume": "115",
      "year": "2010"
    },
    {
      "key": "531_CR30",
      "unstructured": "BECKER LE, MITO T, TAKASHIMA S, ONODERA K, FRIEND WC. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21. APMIS. 1993;101(40 S)."
    },
    {
      "DOI": "10.1007/s00383-018-4344-z",
      "author": "SW Moore",
      "doi-asserted-by": "publisher",
      "first-page": "1127",
      "journal-title": "Pediatr Surg Int",
      "key": "531_CR31",
      "unstructured": "Moore SW. Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR). Pediatr Surg Int. 2018;34:1127–37. https://doi.org/10.1007/s00383-018-4344-z.",
      "volume": "34",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.mod.2008.11.002",
      "author": "RJ Roper",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "issue": "3-4",
      "journal-title": "Mech Develop",
      "key": "531_CR32",
      "unstructured": "Roper RJ, VanHorn JF, Cain CC, Reeves RH. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Develop. 2009;126(3–4):212–9. https://doi.org/10.1016/j.mod.2008.11.002.",
      "volume": "126",
      "year": "2009"
    },
    {
      "DOI": "10.1038/onc.2014.400",
      "author": "H Wu",
      "doi-asserted-by": "publisher",
      "journal-title": "Oncogene",
      "key": "531_CR33",
      "unstructured": "Wu H, Zheng J, Deng J, Zhang L, Li N, Li W, Li F, Lu J, Zhou Y. LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis. Oncogene. 2014. https://doi.org/10.1038/onc.2014.400.",
      "year": "2014"
    },
    {
      "DOI": "10.1182/bloodadvances.2020002090",
      "author": "AG Davis",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "issue": "5",
      "journal-title": "Blood Adv",
      "key": "531_CR34",
      "unstructured": "Davis AG, Einstein JM, Zheng D, Jayne ND, Fu XD, Tian B, et al. A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation. Blood Adv. 2021;5(5):1310–23.",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.3390/genes12111833",
      "author": "H Atas-Ozcan",
      "doi-asserted-by": "crossref",
      "first-page": "1833",
      "issue": "12",
      "journal-title": "Genes",
      "key": "531_CR35",
      "unstructured": "Atas-Ozcan H, Brault V, Duchon A, Herault Y. Dyrk1a from Gene function in development and physiology to dosage correction across life span in Down syndrome. Genes. 2021;2021(12):1833.",
      "volume": "2021",
      "year": "2021"
    },
    {
      "DOI": "10.1242/dmm.035634",
      "author": "TL Nguyen",
      "doi-asserted-by": "publisher",
      "journal-title": "DMM Dis Mod Mech",
      "key": "531_CR36",
      "unstructured": "Nguyen TL, Duchon A, Manousopoulou A, Loaëc N, Villiers B, Pani G, et al. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A. DMM Dis Mod Mech. 2018. https://doi.org/10.1242/dmm.035634.",
      "year": "2018"
    },
    {
      "DOI": "10.1007/978-981-10-3233-2_5",
      "doi-asserted-by": "crossref",
      "key": "531_CR37",
      "unstructured": "Bonifer C, Levantini E, Kouskoff V, Lacaud G. Runx1 structure and function in blood cell development. In: Advances in Experimental Medicine and Biology. 2017."
    },
    {
      "DOI": "10.1016/j.exphem.2018.10.009",
      "author": "L Gao",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Exper Hemat",
      "key": "531_CR38",
      "unstructured": "Gao L, Tober J, Gao P, Chen C, Tan K, Speck NA. RUNX1 and the endothelial origin of blood. Exper Hemat. 2018;68:2–9. https://doi.org/10.1016/j.exphem.2018.10.009.",
      "volume": "68",
      "year": "2018"
    },
    {
      "DOI": "10.1182/blood-2016-10-687830",
      "doi-asserted-by": "crossref",
      "key": "531_CR39",
      "unstructured": "Sood R, Kamikubo Y, Liu P. Review Series TRANSCRIPTION FACTORS IN HEMATOPOIESIS AND HEMATOLOGIC DISEASE Role of RUNX1 in hematological malignancies. Available from: http://ashpublications.org/blood/article-pdf/129/15/2070/1400307/blood687830.pdf."
    },
    {
      "key": "531_CR40",
      "unstructured": "Yokota A, Huo L, Lan F, Wu J, Huang G. The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies. Mol cells. 2020."
    },
    {
      "DOI": "10.1172/JCI73313",
      "author": "S Goyama",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Invest",
      "key": "531_CR41",
      "unstructured": "Goyama S, Schibler J, Cunningham L, Zhang Y, Rao Y, Nishimoto N, et al. Erratum: transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. J Clin Invest. 2013. https://doi.org/10.1172/JCI73313.",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s11899-016-0338-x",
      "doi-asserted-by": "crossref",
      "key": "531_CR42",
      "unstructured": "Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. 2016."
    },
    {
      "DOI": "10.1128/MCB.23.14.5031-5042.2003",
      "doi-asserted-by": "crossref",
      "key": "531_CR43",
      "unstructured": "Rylski M, Welch JJ, Chen YY, Letting DL, Diehl JA, Chodosh LA, et al. GATA-1-Mediated Proliferation Arrest during Erythroid Maturation. Mol Cell Biol. 2003;23(14)."
    },
    {
      "DOI": "10.1182/blood.V112.11.2248.2248",
      "doi-asserted-by": "crossref",
      "key": "531_CR44",
      "unstructured": "Klusmann JH, Godinho F, Pushpanathan T, Reinhardt D, Orkin SH, Li Z. GATA1s Mutant Protein Contributes to “Down” Syndrome Megakaryoblastic Leukemia by Derepression of E2F Targets. Blood. 2008;112(11)."
    },
    {
      "DOI": "10.1101/gad.1903410",
      "doi-asserted-by": "crossref",
      "key": "531_CR45",
      "unstructured": "Klusmann JH, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D, et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev. 2010;24(15)."
    },
    {
      "DOI": "10.1038/leu.2013.373",
      "author": "A Maroz",
      "doi-asserted-by": "publisher",
      "journal-title": "Leukemia",
      "key": "531_CR46",
      "unstructured": "Maroz A, Stachorski L, Emmrich S, Reinhardt K, Xu J, Shao Z, et al. GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. Leukemia. 2014. https://doi.org/10.1038/leu.2013.373.",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrc1525",
      "author": "JK Hitzler",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Rev Cancer",
      "key": "531_CR47",
      "unstructured": "Hitzler JK, Zipursky A. Origins of leukaemia in children with down syndrome. Nat Rev Cancer. 2005. https://doi.org/10.1038/nrc1525.",
      "year": "2005"
    },
    {
      "DOI": "10.1038/gim.2016.23",
      "author": "H Hasle",
      "doi-asserted-by": "publisher",
      "journal-title": "Genet Med",
      "key": "531_CR48",
      "unstructured": "Hasle H, Friedman JM, Olsen JH, Rasmussen SA. Low risk of solid tumors in persons with Down syndrome. Genet Med. 2016. https://doi.org/10.1038/gim.2016.23.",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.bcp.2022.115046",
      "author": "A Gupte",
      "doi-asserted-by": "publisher",
      "journal-title": "Biochem Pharmacol",
      "key": "531_CR49",
      "unstructured": "Gupte A, Al-Antary ET, Edwards H, Ravindranath Y, Ge Y, Taub JW. The paradox of Myeloid Leukemia associated with Down syndrome. Biochem Pharmacol. 2022. https://doi.org/10.1016/j.bcp.2022.115046.",
      "year": "2022"
    },
    {
      "DOI": "10.1111/j.1365-2141.2009.07789.x",
      "author": "A Roy",
      "doi-asserted-by": "publisher",
      "journal-title": "British J Haematol",
      "key": "531_CR50",
      "unstructured": "Roy A, Roberts I, Norton A, Vyas P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. British J Haematol. 2009. https://doi.org/10.1111/j.1365-2141.2009.07789.x.",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2007-04-085670",
      "doi-asserted-by": "crossref",
      "key": "531_CR51",
      "unstructured": "Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, et al. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. 2008; Available from: http://ashpublications.org/blood/article-pdf/111/2/767/1220455/zh800208000767.pdf."
    },
    {
      "DOI": "10.1182/blood-2008-06-161422",
      "author": "CL Carmichael",
      "doi-asserted-by": "crossref",
      "first-page": "1929",
      "journal-title": "Blood.",
      "key": "531_CR52",
      "unstructured": "Carmichael CL, Majewski IJ, Alexander WS, Metcalf D, Hilton DJ, Hewitt CA, et al. Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood. 2009;113:1929–37.",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2009-06-227629",
      "author": "KA Alford",
      "doi-asserted-by": "crossref",
      "first-page": "2928",
      "issue": "14",
      "journal-title": "Blood",
      "key": "531_CR53",
      "unstructured": "Alford KA, Slender A, Vanes L, Li Z, Fisher EMC, Nizetic D, et al. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood. 2010;115(14):2928–37.",
      "volume": "115",
      "year": "2010"
    },
    {
      "DOI": "10.1182/blood.V112.11.2790.2790",
      "author": "KA Alford",
      "doi-asserted-by": "publisher",
      "journal-title": "Blood",
      "key": "531_CR54",
      "unstructured": "Alford KA, Vanes L, Li Z, Orkin SH, Fisher EMC, Tybulewicz VLJ. A myeloproliferative disorder in the Tc1 mouse model of Down syndrome. Blood. 2008. https://doi.org/10.1182/blood.V112.11.2790.2790.",
      "year": "2008"
    },
    {
      "DOI": "10.1182/blood-2002-09-2708",
      "author": "KE Elagib",
      "doi-asserted-by": "publisher",
      "journal-title": "Blood",
      "key": "531_CR55",
      "unstructured": "Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood. 2003. https://doi.org/10.1182/blood-2002-09-2708.",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.leu.2404223",
      "author": "G Xu",
      "doi-asserted-by": "crossref",
      "first-page": "1002",
      "issue": "6",
      "journal-title": "Leukemia",
      "key": "531_CR56",
      "unstructured": "Xu G, Kanezaki R, Toki T, Watanabe S, Takahashi Y, Terui K, et al. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome. Leukemia. 2006;20(6):1002–8.",
      "volume": "20",
      "year": "2006"
    },
    {
      "DOI": "10.1038/onc.2010.351",
      "author": "S De Vita",
      "doi-asserted-by": "crossref",
      "first-page": "6102",
      "issue": "46",
      "journal-title": "Oncogene",
      "key": "531_CR57",
      "unstructured": "De Vita S, Canzonetta C, Mulligan C, Delom F, Groet J, Baldo C, et al. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down’s syndrome. Oncogene. 2010;29(46):6102–14.",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41417-020-00262-9",
      "author": "L Vukadin",
      "doi-asserted-by": "crossref",
      "first-page": "1000",
      "issue": "9",
      "journal-title": "Cancer Gene Ther",
      "key": "531_CR58",
      "unstructured": "Vukadin L, Kim JH, Park EY, Stone JK, Ungerleider N, Baddoo MC, et al. SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia. Cancer Gene Ther. 2021;28(9):1000–15.",
      "volume": "28",
      "year": "2021"
    },
    {
      "DOI": "10.1073/pnas.0511150103",
      "doi-asserted-by": "crossref",
      "key": "531_CR59",
      "unstructured": "Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. 2006. Available from: www.ncbi.nlm.nih.govgeo"
    },
    {
      "DOI": "10.1093/hmg/ddaa218",
      "author": "BI Laufer",
      "doi-asserted-by": "crossref",
      "first-page": "3465",
      "issue": "21",
      "journal-title": "Hum Mol Genet",
      "key": "531_CR60",
      "unstructured": "Laufer BI, Hwang H, Jianu JM, Mordaunt CE, Korf IF, Hertz-Picciotto I, et al. Low-pass whole genome bisulfite sequencing of neonatal dried blood spots identifies a role for RUNX1 in down syndrome DNA methylation profiles. Hum Mol Genet. 2020;29(21):3465–76.",
      "volume": "29",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41467-021-21064-z",
      "author": "IS Muskens",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "531_CR61",
      "unstructured": "Muskens IS, Li S, Jackson T, Elliot N, Hansen HM, Myint SS, et al. The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nat Commun. 2021. https://doi.org/10.1038/s41467-021-21064-z.",
      "year": "2021"
    },
    {
      "author": "N Mollo",
      "first-page": "13",
      "journal-title": "Front Genet",
      "key": "531_CR62",
      "unstructured": "Mollo N, Aurilia M, Scognamiglio R, Zerillo L, Cicatiello R, Bonfiglio F, et al. Overexpression of the Hsa21 transcription factor RUNX1 modulates the extracellular matrix in trisomy 21 cells. Front Genet. 2022;10:13.",
      "volume": "10",
      "year": "2022"
    },
    {
      "DOI": "10.1186/gb-2010-11-6-r64",
      "author": "R De Cegli",
      "doi-asserted-by": "publisher",
      "journal-title": "Genome Biol",
      "key": "531_CR63",
      "unstructured": "De Cegli R, Romito A, Iacobacci S, Mao L, Lauria M, Fedele AO, et al. A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes. Genome Biol. 2010. https://doi.org/10.1186/gb-2010-11-6-r64.",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ejmg.2015.11.003",
      "author": "C Stoll",
      "doi-asserted-by": "publisher",
      "journal-title": "Eur J Med Genet",
      "key": "531_CR64",
      "unstructured": "Stoll C, Dott B, Alembik Y, Roth MP. Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet. 2015. https://doi.org/10.1016/j.ejmg.2015.11.003.",
      "year": "2015"
    },
    {
      "DOI": "10.1172/JCI85003",
      "author": "RO Heuckeroth",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Invest",
      "key": "531_CR65",
      "unstructured": "Heuckeroth RO. Hirschsprung’s disease, Down syndrome, and missing heritability: too much collagen slows migration. J Clin Invest. 2015. https://doi.org/10.1172/JCI85003.",
      "year": "2015"
    },
    {
      "DOI": "10.1152/ajpheart.00136.2018",
      "author": "T Thenappan",
      "doi-asserted-by": "crossref",
      "first-page": "1322",
      "journal-title": "Rev Extracell Matrix Cardiovasc Pathophysiol Am J Physiol Heart Circ Physiol",
      "key": "531_CR66",
      "unstructured": "Thenappan T, Chan SY, Kenneth Weir E. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Rev Extracell Matrix Cardiovasc Pathophysiol Am J Physiol Heart Circ Physiol. 2018;315:1322–31.",
      "volume": "315",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.stemcr.2016.08.003",
      "author": "T Halevy",
      "doi-asserted-by": "crossref",
      "first-page": "777",
      "issue": "4",
      "journal-title": "Stem Cell Rep",
      "key": "531_CR67",
      "unstructured": "Halevy T, Biancotti JC, Yanuka O, Golan-Lev T, Benvenisty N. Molecular characterization of Down syndrome embryonic stem cells reveals a role for RUNX1 in neural differentiation. Stem Cell Rep. 2016;7(4):777–86.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.14348/molcells.2022.0095www.molcells.org",
      "doi-asserted-by": "publisher",
      "key": "531_CR68",
      "unstructured": "Liu Y, Zhang Y, Ren Z, Zeng F, Yan J. Molecules and Cells RUNX1 Upregulation Causes Mitochondrial Dysfunction via Regulating the PI3K-Akt Pathway in iPSC from Patients with Down Syndrome. Available from: https://doi.org/10.14348/molcells.2022.0095www.molcells.org."
    },
    {
      "DOI": "10.1073/pnas.0400768101",
      "author": "FM Theriault",
      "doi-asserted-by": "crossref",
      "first-page": "10343",
      "issue": "28",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "531_CR69",
      "unstructured": "Theriault FM, Roy P, Stifani S. AML1/Runx1 is important for the development of hindbrain cholinergic branchiovisceral motor neurons and selected cranial sensory neurons. Proc Natl Acad Sci U S A. 2004;101(28):10343–8.",
      "volume": "101",
      "year": "2004"
    },
    {
      "DOI": "10.1523/JNEUROSCI.5108-04.2005",
      "author": "FM Theriault",
      "doi-asserted-by": "crossref",
      "first-page": "2050",
      "issue": "8",
      "journal-title": "J Neurosci",
      "key": "531_CR70",
      "unstructured": "Theriault FM, Nuthall HN, Dong Z, Lo R, Barnabe-Heider F, Miller FD, et al. Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J Neurosci. 2005;25(8):2050–61.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.scr.2015.09.014",
      "author": "TT Logan",
      "doi-asserted-by": "crossref",
      "first-page": "554",
      "issue": "3",
      "journal-title": "Stem Cell Res",
      "key": "531_CR71",
      "unstructured": "Logan TT, Rusnak M, Symes AJ. Runx1 promotes proliferation and neuronal differentiation in adult mouse neurosphere cultures. Stem Cell Res. 2015;15(3):554–64.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0190789",
      "author": "H Fukui",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "531_CR72",
      "unstructured": "Fukui H, Rünker A, Fabel K, Buchholz F, Kempermann G. Transcription factor Runx1 is pro-neurogenic in adult hippocampal precursor cells. PLoS One. 2018. https://doi.org/10.1371/journal.pone.0190789.",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.devcel.2023.01.008",
      "author": "BR Shrestha",
      "doi-asserted-by": "crossref",
      "first-page": "306",
      "issue": "4",
      "journal-title": "Dev Cell",
      "key": "531_CR73",
      "unstructured": "Shrestha BR, Wu L, Goodrich LV. Runx1 controls auditory sensory neuron diversity in mice. Dev Cell. 2023;58(4):306–19.",
      "volume": "58",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.neuron.2005.10.036",
      "author": "CL Chen",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "issue": "3",
      "journal-title": "Neuron",
      "key": "531_CR74",
      "unstructured": "Chen CL, Broom DC, Liu Y, De Nooij JC, Li Z, Cen C, et al. Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron. 2006;49(3):365–77.",
      "volume": "49",
      "year": "2006"
    },
    {
      "DOI": "10.7554/eLife.10874",
      "author": "S Huang",
      "doi-asserted-by": "publisher",
      "journal-title": "Elife",
      "key": "531_CR75",
      "unstructured": "Huang S, O’Donovan KJ, Turner EE, Zhong J, Ginty DD. Extrinsic and intrinsic signals converge on the Runx1/CBFβ transcription factor for nonpeptidergic nociceptor maturation. Elife. 2015. https://doi.org/10.7554/eLife.10874.",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.neuron.2006.01.008",
      "author": "I Kramer",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "issue": "3",
      "journal-title": "Neuron",
      "key": "531_CR76",
      "unstructured": "Kramer I, Sigrist M, De Nooij JC, Taniuchi I, Jessell TM, Arber S. A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron. 2006;49(3):379–93.",
      "volume": "49",
      "year": "2006"
    },
    {
      "DOI": "10.3389/fncel.2022.941855",
      "doi-asserted-by": "crossref",
      "key": "531_CR77",
      "unstructured": "Citation Klein JA, Haydar TF. Open access edited by Neurodevelopment in Down syndrome: Concordance in humans and models. 2022."
    },
    {
      "DOI": "10.1007/s10072-022-06500-2",
      "author": "L Brozzetti",
      "doi-asserted-by": "publisher",
      "journal-title": "Neurol Sci",
      "key": "531_CR78",
      "unstructured": "Brozzetti L, Scambi I, Bertoldi L, Zanini A, Malacrida G, Sacchetto L, et al. RNAseq analysis of olfactory neuroepithelium cytological samples in individuals with Down syndrome compared to euploid controls: a pilot study. Neurol Sci. 2023. https://doi.org/10.1007/s10072-022-06500-2.",
      "year": "2023"
    },
    {
      "DOI": "10.2174/1871527315666160801143108",
      "author": "S Guidi",
      "doi-asserted-by": "publisher",
      "journal-title": "CNS Neurol Disord Drug Targets",
      "key": "531_CR79",
      "unstructured": "Guidi S, Bianchi P, Stagni F, Giacomini A, Emili M, Trazzi S, et al. Lithium restores age-related olfactory impairment in the Ts65Dn mouse model of Down syndrome. CNS Neurol Disord Drug Targets. 2016. https://doi.org/10.2174/1871527315666160801143108.",
      "year": "2016"
    },
    {
      "DOI": "10.1523/JNEUROSCI.0534-10.2010",
      "author": "P Bianchi",
      "doi-asserted-by": "publisher",
      "journal-title": "J Neurosci",
      "key": "531_CR80",
      "unstructured": "Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G, et al. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for down syndrome. J Neurosci. 2010. https://doi.org/10.1523/JNEUROSCI.0534-10.2010.",
      "year": "2010"
    },
    {
      "DOI": "10.1093/brain/awt340",
      "author": "S Guidi",
      "doi-asserted-by": "publisher",
      "journal-title": "Brain",
      "key": "531_CR81",
      "unstructured": "Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, et al. Prenatal pharmacotherapy rescues brain development in a Down’s syndrome mouse model. Brain. 2014. https://doi.org/10.1093/brain/awt340.",
      "year": "2014"
    },
    {
      "DOI": "10.3389/fnagi.2021.719507",
      "author": "S Do Carmo",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Aging Neurosci",
      "key": "531_CR82",
      "unstructured": "Do Carmo S, Kannel B, Cuello AC. Nerve growth factor compromise in Down syndrome. Front Aging Neurosci. 2021. https://doi.org/10.3389/fnagi.2021.719507.",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pgen.1007383",
      "author": "S Watson-Scales",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Genet",
      "key": "531_CR83",
      "unstructured": "Watson-Scales S, Kalmar B, Lana-Elola E, Gibbins D, La Russa F, Wiseman F, et al. Analysis of motor dysfunction in Down syndrome reveals motor neuron degeneration. PLoS Genet. 2018. https://doi.org/10.1371/journal.pgen.1007383.",
      "year": "2018"
    },
    {
      "DOI": "10.1177/0194599810391204",
      "author": "T Inagaki",
      "doi-asserted-by": "crossref",
      "first-page": "280",
      "issue": "2",
      "journal-title": "Otolaryngol Head Neck Surg",
      "key": "531_CR84",
      "unstructured": "Inagaki T, Morita N, Cureoglu S, Schachern PA, Nomiya S, Nomiya R, et al. Peripheral vestibular system in Down syndrome: quantitative assessment of vestibular histopathology. Otolaryngol Head Neck Surg. 2011;144(2):280–3.",
      "volume": "144",
      "year": "2011"
    },
    {
      "author": "CG Di",
      "first-page": "13",
      "journal-title": "Front Genet",
      "key": "531_CR85",
      "unstructured": "Di CG, Li L, McCall A, Ding D, Xing Z, Yu YE, et al. Hearing impairment in murine model of Down syndrome. Front Genet. 2022;4:13.",
      "volume": "4",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.heliyon.2022.e12656",
      "doi-asserted-by": "crossref",
      "key": "531_CR86",
      "unstructured": "Liu Y, Huang C, Bai M, Pi C, Zhang D, Xie J. The roles of Runx1 in skeletal development and osteoarthritis: a concise review. vol. 8, Heliyon. Elsevier Ltd; 2022."
    },
    {
      "DOI": "10.1016/S0925-4773(03)00101-1",
      "author": "T Yamashiro",
      "doi-asserted-by": "publisher",
      "journal-title": "Mech Dev",
      "key": "531_CR87",
      "unstructured": "Yamashiro T, Åberg T, Levanon D, Groner Y, Thesleff I. Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development. Mech Dev. 2002. https://doi.org/10.1016/S0925-4773(03)00101-1.",
      "year": "2002"
    },
    {
      "DOI": "10.1002/jcp.10316",
      "author": "JB Lian",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "issue": "2",
      "journal-title": "J Cell Physiol",
      "key": "531_CR88",
      "unstructured": "Lian JB, Balint E, Javed A, Drissi H, Vitti R, Quinlan EJ, et al. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo. J Cell Physiol. 2003;196(2):301–11.",
      "volume": "196",
      "year": "2003"
    },
    {
      "DOI": "10.1210/me.2013-1305",
      "author": "DY Soung",
      "doi-asserted-by": "crossref",
      "first-page": "546",
      "issue": "4",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR89",
      "unstructured": "Soung DY, Kalinowski J, Baniwal SK, Jacome-Galarza CE, Frenkel B, Lorenzo J, et al. Runx1-mediated regulation of osteoclast differentiation and function. Mol Endocrinol. 2014;28(4):546–53.",
      "volume": "28",
      "year": "2014"
    },
    {
      "DOI": "10.1042/BCJ20200036",
      "author": "CY Tang",
      "doi-asserted-by": "crossref",
      "first-page": "2421",
      "issue": "13",
      "journal-title": "Biochem J",
      "key": "531_CR90",
      "unstructured": "Tang CY, Chen W, Luo Y, Wu J, Zhang Y, McVicar A, et al. Runx1 up-regulates chondrocyte to osteoblast lineage commitment and promotes bone formation by enhancing both chondrogenesis and osteogenesis. Biochem J. 2020;477(13):2421–38.",
      "volume": "477",
      "year": "2020"
    },
    {
      "DOI": "10.1074/jbc.RA119.007896",
      "author": "J Tang",
      "doi-asserted-by": "crossref",
      "first-page": "11669",
      "issue": "33",
      "journal-title": "J Biol Chem",
      "key": "531_CR91",
      "unstructured": "Tang J, Xie J, Chen W, Tang C, Wu J, Wang Y, et al. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation. J Biol Chem. 2020;295(33):11669–81.",
      "volume": "295",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pgen.1009233",
      "author": "CY Tang",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Genet",
      "key": "531_CR92",
      "unstructured": "Tang CY, Wu M, Zhao D, Edwards D, McVicar A, Luo Y, et al. Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways. PLoS Genet. 2021. https://doi.org/10.1371/journal.pgen.1009233.",
      "year": "2021"
    },
    {
      "DOI": "10.1002/jor.24537",
      "author": "DN Paglia",
      "doi-asserted-by": "crossref",
      "first-page": "1007",
      "issue": "5",
      "journal-title": "J Orthop Res",
      "key": "531_CR93",
      "unstructured": "Paglia DN, Diaz-Hernandez ME, Roberts JL, Kalinowski J, Lorenzo J, Drissi H. Deletion of Runx1 in osteoclasts impairs murine fracture healing through progressive woven bone loss and delayed cartilage remodeling. J Orthop Res. 2020;38(5):1007–15.",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41413-021-00173-x",
      "author": "C Zhou",
      "doi-asserted-by": "publisher",
      "journal-title": "Bone Res",
      "key": "531_CR94",
      "unstructured": "Zhou C, Cui Y, Yang Y, Guo D, Zhang D, Fan Y, et al. Runx1 protects against the pathological progression of osteoarthritis. Bone Res. 2021. https://doi.org/10.1038/s41413-021-00173-x.",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s11914-021-00674-y",
      "author": "JR Thomas",
      "doi-asserted-by": "publisher",
      "journal-title": "Curr Osteoporosis Rep",
      "key": "531_CR95",
      "unstructured": "Thomas JR, Roper RJ. Current analysis of skeletal phenotypes in Down Syndrome. Curr Osteoporosis Rep. 2021. https://doi.org/10.1007/s11914-021-00674-y.",
      "year": "2021"
    },
    {
      "DOI": "10.1093/hmg/ddv284",
      "author": "JD Blazek",
      "doi-asserted-by": "crossref",
      "first-page": "5687",
      "issue": "20",
      "journal-title": "Hum Mol Genet",
      "key": "531_CR96",
      "unstructured": "Blazek JD, Abeysekera I, Li J, Roper RJ. Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a. Hum Mol Genet. 2015;24(20):5687–96.",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1242/dmm.049927",
      "author": "K Sloan",
      "doi-asserted-by": "publisher",
      "journal-title": "Dis Models Mech",
      "key": "531_CR97",
      "unstructured": "Sloan K, Thomas J, Blackwell M, Voisard D, Lana-Elola E, Watson-Scales S, et al. Genetic dissection of triplicated Hsa21 orthologs produces differential skeletal phenotypes in Down syndrome mouse models. Dis Models Mech. 2023. https://doi.org/10.1242/dmm.049927.",
      "year": "2023"
    },
    {
      "DOI": "10.1203/00006450-199807000-00015",
      "author": "M Garcia-Ramírez",
      "doi-asserted-by": "publisher",
      "journal-title": "Pediatr Res",
      "key": "531_CR98",
      "unstructured": "Garcia-Ramírez M, Toran N, Carrascosa A, Audi L. Down’s syndrome: altered chondrogenesis in fetal rib. Pediatr Res. 1998. https://doi.org/10.1203/00006450-199807000-00015.",
      "year": "1998"
    },
    {
      "DOI": "10.2147/PHMT.S282646",
      "author": "JT Jones",
      "doi-asserted-by": "crossref",
      "first-page": "53",
      "journal-title": "Pediatric Health Med Ther",
      "key": "531_CR99",
      "unstructured": "Jones JT, Kitchen J, Talib N. Down syndrome-associated arthritis (DA): diagnostic and management challenges. Pediatric Health Med Ther. 2022;13:53–62.",
      "volume": "13",
      "year": "2022"
    },
    {
      "key": "531_CR100",
      "unstructured": "Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, et al. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis [Internet]. Available from: www.elsevier.com/locate/modo."
    },
    {
      "DOI": "10.1016/j.yjmcc.2015.07.021",
      "author": "G Lluri",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "issue": "86",
      "journal-title": "J Mol Cell Cardiol",
      "key": "531_CR101",
      "unstructured": "Lluri G, Huang V, Touma M, Liu X, Harmon AW, Nakano A. Hematopoietic progenitors are required for proper development of coronary vasculature. J Mol Cell Cardiol. 2015;1(86):199–207.",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature11739",
      "author": "A Eulalio",
      "doi-asserted-by": "crossref",
      "first-page": "376",
      "issue": "7429",
      "journal-title": "Nature",
      "key": "531_CR102",
      "unstructured": "Eulalio A, Mano M, Ferro MD, Zentilin L, Sinagra G, Zacchigna S, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012;492(7429):376–81.",
      "volume": "492",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s12864-016-2545-1",
      "author": "B Górnikiewicz",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Genom",
      "key": "531_CR103",
      "unstructured": "Górnikiewicz B, Ronowicz A, Krzemiński M, Sachadyn P. Changes in gene methylation patterns in neonatal murine hearts: Implications for the regenerative potential. BMC Genom. 2016. https://doi.org/10.1186/s12864-016-2545-1.",
      "year": "2016"
    },
    {
      "DOI": "10.1093/cvr/cvaa034",
      "author": "A Riddell",
      "doi-asserted-by": "publisher",
      "journal-title": "Cardiovasc Res",
      "key": "531_CR104",
      "unstructured": "Riddell A, McBride M, Braun T, Nicklin SA, Cameron E, Loughrey CM, et al. RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovasc Res. 2020. https://doi.org/10.1093/cvr/cvaa034.",
      "year": "2020"
    },
    {
      "DOI": "10.1016/S0002-9440(10)63467-0",
      "author": "S Gattenlöhner",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Pathol",
      "key": "531_CR105",
      "unstructured": "Gattenlöhner S, Waller C, Ertl G, Bültmann BD, Müller-Hermelink HK, Marx A. NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. Am J Pathol. 2003. https://doi.org/10.1016/S0002-9440(10)63467-0.",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.stem.2011.08.013",
      "author": "T Kubin",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Stem Cell",
      "key": "531_CR106",
      "unstructured": "Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011. https://doi.org/10.1016/j.stem.2011.08.013.",
      "year": "2011"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.117.028911",
      "author": "CS McCarroll",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "issue": "1",
      "journal-title": "Circulation",
      "key": "531_CR107",
      "unstructured": "McCarroll CS, He W, Foote K, Bradley A, McGlynn K, Vidler F, et al. Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation. 2018;137(1):57–70.",
      "volume": "137",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jacbts.2019.05.006",
      "author": "S Ikeda",
      "doi-asserted-by": "publisher",
      "journal-title": "JACC Basic Transl Sci",
      "key": "531_CR108",
      "unstructured": "Ikeda S, Mukai R, Mizushima W, Zhai P, Ichi OS, Nakamura M, et al. Yes-associated protein (YAP) facilitates pressure overload-induced dysfunction in the diabetic heart. JACC Basic Transl Sci. 2019. https://doi.org/10.1016/j.jacbts.2019.05.006.",
      "year": "2019"
    },
    {
      "DOI": "10.1093/abbs/gmv137",
      "author": "X Zhang",
      "doi-asserted-by": "publisher",
      "journal-title": "Acta Biochim Biophys Sin",
      "key": "531_CR109",
      "unstructured": "Zhang X, Ma S, Zhang R, Li S, Zhu D, Han D, et al. Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway. Acta Biochim Biophys Sin. 2015. https://doi.org/10.1093/abbs/gmv137.",
      "year": "2015"
    },
    {
      "DOI": "10.1101/2022.02.17.480749",
      "doi-asserted-by": "publisher",
      "key": "531_CR110",
      "unstructured": "Martin TP, Macdonald EA, Bradley A, Watson H, Saxena P, Rog-Zielinska EA, et al. Inhibiting Runx1 protects heart function after myocardial infarction. 2022. https://doi.org/10.1101/2022.02.17.480749."
    },
    {
      "DOI": "10.1101/2022.09.15.508152",
      "doi-asserted-by": "crossref",
      "key": "531_CR111",
      "unstructured": "Swift SK, Purdy AL, Kolell ME, Andresen KG, Lahue C, Buddell T, et al. Cardiomyocyte ploidy is dynamic during postnatal development and varies across genetic backgrounds. 2023."
    },
    {
      "DOI": "10.1002/ar.a.10126",
      "author": "AC Gittenberger-De Groot",
      "doi-asserted-by": "publisher",
      "journal-title": "Anat Record A Discover Mol Cell Evolut Biol",
      "key": "531_CR112",
      "unstructured": "Gittenberger-De Groot AC, Bartram U, Oosthoek PW, Bartelings MM, Hogers B, Poelmann RE, et al. Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Record A Discover Mol Cell Evolut Biol. 2003. https://doi.org/10.1002/ar.a.10126.",
      "year": "2003"
    },
    {
      "DOI": "10.1186/1471-2164-8-268",
      "author": "A Conti",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Genom",
      "key": "531_CR113",
      "unstructured": "Conti A, Fabbrini F, D’Agostino P, Negri R, Greco D, Genesio R, et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genom. 2007. https://doi.org/10.1186/1471-2164-8-268.",
      "year": "2007"
    },
    {
      "DOI": "10.1002/(SICI)1096-8628(19981116)80:3\u003c213::AID-AJMG6\u003e3.0.CO;2-8",
      "doi-asserted-by": "crossref",
      "key": "531_CR114",
      "unstructured": "Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998;80(3)."
    },
    {
      "DOI": "10.1016/S0140-6736(03)12987-X",
      "author": "NJ Roizen",
      "doi-asserted-by": "publisher",
      "journal-title": "Seminar",
      "key": "531_CR115",
      "unstructured": "Roizen NJ, Patterson D. Down’ s syndrome. Seminar. 2003. https://doi.org/10.1016/S0140-6736(03)12987-X.",
      "year": "2003"
    },
    {
      "DOI": "10.1093/eurpub/ckl103",
      "author": "AH Bittles",
      "doi-asserted-by": "publisher",
      "journal-title": "Eur J Public Health",
      "key": "531_CR116",
      "unstructured": "Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health. 2007. https://doi.org/10.1093/eurpub/ckl103.",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.gendis.2019.06.007",
      "author": "H Zhang",
      "doi-asserted-by": "publisher",
      "journal-title": "Genes Dis",
      "key": "531_CR117",
      "unstructured": "Zhang H, Liu L, Tian J. Molecular mechanisms of congenital heart disease in down syndrome. Genes Dis. 2019. https://doi.org/10.1016/j.gendis.2019.06.007.",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fgene.2021.792231",
      "author": "L Venegas-Zamora",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Genet",
      "key": "531_CR118",
      "unstructured": "Venegas-Zamora L, Bravo-Acuña F, Sigcho F, Gomez W, Bustamante-Salazar J, Pedrozo Z, et al. New molecular and organelle alterations linked to Down syndrome heart disease. Front Genet. 2022. https://doi.org/10.3389/fgene.2021.792231.",
      "year": "2022"
    },
    {
      "DOI": "10.1002/aja.1002030107",
      "author": "A Simeone",
      "doi-asserted-by": "publisher",
      "journal-title": "Develop Dyn",
      "key": "531_CR119",
      "unstructured": "Simeone A, Daga A, Calabi F. Expression of runt in the mouse embryo. Develop Dyn. 1995. https://doi.org/10.1002/aja.1002030107.",
      "year": "1995"
    },
    {
      "DOI": "10.1128/MCB.14.12.8051",
      "author": "X Zhu",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cell Biol",
      "key": "531_CR120",
      "unstructured": "Zhu X, Yeadon JE, Burden SJ. AML1 is expressed in skeletal muscle and is regulated by innervation. Mol Cell Biol. 1994. https://doi.org/10.1128/MCB.14.12.8051.",
      "year": "1994"
    },
    {
      "DOI": "10.1093/hmg/ddg197",
      "author": "JD Porter",
      "doi-asserted-by": "publisher",
      "journal-title": "Human Mol Genet",
      "key": "531_CR121",
      "unstructured": "Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Human Mol Genet. 2003. https://doi.org/10.1093/hmg/ddg197.",
      "year": "2003"
    },
    {
      "DOI": "10.1152/physiolgenomics.00017.2007",
      "doi-asserted-by": "publisher",
      "key": "531_CR122",
      "unstructured": "Gonzalez De Aguilar JL, Niederhauser-Wiederkehr C, Halter B, De Tapia M, Di Scala F, Demougin P, et al. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Phys Gen. 2008. https://doi.org/10.1152/physiolgenomics.00017.2007"
    },
    {
      "DOI": "10.1093/brain/awl023",
      "author": "M Bakay",
      "doi-asserted-by": "publisher",
      "journal-title": "Brain",
      "key": "531_CR123",
      "unstructured": "Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain. 2006. https://doi.org/10.1093/brain/awl023.",
      "year": "2006"
    },
    {
      "DOI": "10.1074/jbc.M202668200",
      "author": "P Zhao",
      "doi-asserted-by": "publisher",
      "journal-title": "J Biol Chem",
      "key": "531_CR124",
      "unstructured": "Zhao P, Iezzi S, Carver E, Dressman D, Gridley T, Sartorelli V, et al. Slug is a novel downstream target of MyoD Temporal profiling in muscle regeneration. J Biol Chem. 2002. https://doi.org/10.1074/jbc.M202668200.",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.bbrc.2018.08.083",
      "author": "M Bao",
      "doi-asserted-by": "crossref",
      "first-page": "2993",
      "issue": "4",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "531_CR125",
      "unstructured": "Bao M, Liu S, Yu XY, Wu C, Chen Q, Ding H, et al. Runx1 promotes satellite cell proliferation during ischemia-Induced muscle regeneration. Biochem Biophys Res Commun. 2018;503(4):2993–7.",
      "volume": "503",
      "year": "2018"
    },
    {
      "DOI": "10.4161/epi.25441",
      "author": "R Blum",
      "doi-asserted-by": "publisher",
      "journal-title": "Epigenetics",
      "key": "531_CR126",
      "unstructured": "Blum R, Dynlacht BD. The role of MyoD1 and histone modifications in the activation of muscle enhancers. Epigenetics. 2013. https://doi.org/10.4161/epi.25441.",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0009425",
      "author": "O Philipot",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "531_CR127",
      "unstructured": "Philipot O, Joliot V, Ait-Mohamed O, Pellentz C, Robin P, Fritsch L, et al. The core binding factor CBF negatively regulates skeletal muscle terminal differentiation. PLoS One. 2010. https://doi.org/10.1371/journal.pone.0009425.",
      "year": "2010"
    },
    {
      "DOI": "10.1186/2044-5040-2-7",
      "author": "KL MacQuarrie",
      "doi-asserted-by": "publisher",
      "journal-title": "Skelet Muscle",
      "key": "531_CR128",
      "unstructured": "MacQuarrie KL, Yao Z, Young JM, Cao Y, Tapscott SJ. MiR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells. Skelet Muscle. 2012. https://doi.org/10.1186/2044-5040-2-7.",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.gdata.2015.08.030",
      "author": "KB Umansky",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "issue": "6",
      "journal-title": "Genom Data",
      "key": "531_CR129",
      "unstructured": "Umansky KB, Feldmesser E, Groner Y. Genomic-wide transcriptional profiling in primary myoblasts reveals Runx1-regulated genes in muscle regeneration. Genom Data. 2015;1(6):120–2.",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pgen.1005457",
      "author": "KB Umansky",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Genet",
      "key": "531_CR130",
      "unstructured": "Umansky KB, Gruenbaum-Cohen Y, Tsoory M, Feldmesser E, Goldenberg D, Brenner O, et al. Runx1 Transcription Factor Is Required for Myoblasts Proliferation during Muscle Regeneration. PLoS Genet. 2015. https://doi.org/10.1371/journal.pgen.1005457.",
      "year": "2015"
    },
    {
      "DOI": "10.1530/EJE-21-0776",
      "author": "M Stefanowicz",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "issue": "1",
      "journal-title": "Eur J Endocrinol",
      "key": "531_CR131",
      "unstructured": "Stefanowicz M, Nikołajuk A, Matulewicz N, Strączkowski M, Karczewska-Kupczewska M. Skeletal muscle RUNX1 is related to insulin sensitivity through its effect on myogenic potential. Eur J Endocrinol. 2022;187(1):143–57.",
      "volume": "187",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.stem.2021.04.008",
      "author": "MN Wosczyna",
      "doi-asserted-by": "crossref",
      "first-page": "1323",
      "issue": "7",
      "journal-title": "Cell Stem Cell",
      "key": "531_CR132",
      "unstructured": "Wosczyna MN, Perez Carbajal EE, Wagner MW, Paredes S, Konishi CT, Liu L, et al. Targeting microRNA-mediated gene repression limits adipogenic conversion of skeletal muscle mesenchymal stromal cells. Cell Stem Cell. 2021;28(7):1323-1334.e8.",
      "volume": "28",
      "year": "2021"
    },
    {
      "DOI": "10.1136/archdischild-2018-315751",
      "author": "C Foley",
      "doi-asserted-by": "crossref",
      "first-page": "482",
      "issue": "5",
      "journal-title": "Arch Dis Child",
      "key": "531_CR133",
      "unstructured": "Foley C, Killeen OG. Musculoskeletal anomalies in children with Down syndrome: an observational study. Arch Dis Child. 2019;104(5):482–7.",
      "volume": "104",
      "year": "2019"
    },
    {
      "DOI": "10.3345/cep.2021.00479",
      "author": "PD Jain",
      "doi-asserted-by": "crossref",
      "first-page": "142",
      "issue": "3",
      "journal-title": "Clin Exp Pediatr",
      "key": "531_CR134",
      "unstructured": "Jain PD, Nayak A, Karnad SD, Doctor KN. Gross motor dysfunction and balance impairments in children and adolescents with Down syndrome: a systematic review. Clin Exp Pediatr. 2022;65(3):142–9.",
      "volume": "65",
      "year": "2022"
    },
    {
      "DOI": "10.1017/S143192762002437X",
      "author": "B Cisterna",
      "doi-asserted-by": "crossref",
      "first-page": "1014",
      "issue": "5",
      "journal-title": "Microsc Microanal",
      "key": "531_CR135",
      "unstructured": "Cisterna B, Sobolev AP, Costanzo M, Malatesta M, Zancanaro C. Combined microscopic and metabolomic approach to characterize the skeletal muscle fiber of the Ts65Dn mouse, a model of Down syndrome. Microsc Microanal. 2020;26(5):1014–23.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41598-018-22342-5",
      "author": "B Pawlikowski",
      "doi-asserted-by": "publisher",
      "journal-title": "Sci Rep",
      "key": "531_CR136",
      "unstructured": "Pawlikowski B, Betta ND, Elston T, Williams DA, Olwin BB. Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-22342-5.",
      "year": "2018"
    },
    {
      "DOI": "10.1111/j.1471-4159.2005.03336.x",
      "author": "L Stewart",
      "doi-asserted-by": "crossref",
      "first-page": "1739",
      "issue": "6",
      "journal-title": "J Neurochem",
      "key": "531_CR137",
      "unstructured": "Stewart L, Potok MA, Camper SA, Stifani S. Runx1 expression defines a subpopulation of displaced amacrine cells in the developing mouse retina. J Neurochem. 2005;94(6):1739–45.",
      "volume": "94",
      "year": "2005"
    },
    {
      "DOI": "10.1038/s41467-018-05134-3",
      "author": "BA Rheaume",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "531_CR138",
      "unstructured": "Rheaume BA, Jereen A, Bolisetty M, Sajid MS, Yang Y, Renna K, et al. Single cell transcriptome profiling of retinal ganglion cells identifies cellular subtypes. Nat Commun. 2018. https://doi.org/10.1038/s41467-018-05134-3.",
      "year": "2018"
    },
    {
      "DOI": "10.2337/db16-1035",
      "author": "JD Lam",
      "doi-asserted-by": "crossref",
      "first-page": "1950",
      "issue": "7",
      "journal-title": "Diabetes",
      "key": "531_CR139",
      "unstructured": "Lam JD, Oh DJ, Wong LL, Amarnani D, Park-Windhol C, Sanchez AV, et al. Identification of RUNX1 as a mediator of aberrant retinal angiogenesis. Diabetes. 2017;66(7):1950–6.",
      "volume": "66",
      "year": "2017"
    },
    {
      "DOI": "10.1042/BSR20193256",
      "author": "W Zou",
      "doi-asserted-by": "publisher",
      "key": "531_CR140",
      "unstructured": "Zou W, Zhang Z, Luo S, Cheng L, Huang X, Ding N, et al. P38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy. 2020. Biosci Rep. https://doi.org/10.1042/BSR20193256.",
      "year": "2020"
    },
    {
      "author": "W Zhang",
      "first-page": "217",
      "journal-title": "Exp Eye Res",
      "key": "531_CR141",
      "unstructured": "Zhang W, Zhang D, Cheng Y, Liang X, Wang J. Runx1 regulates Tff1 expression to expedite viability of retinal microvascular endothelial cells in mice with diabetic retinopathy. Exp Eye Res. 2022;1:217.",
      "volume": "1",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41598-020-77254-0",
      "doi-asserted-by": "crossref",
      "key": "531_CR142",
      "unstructured": "Delgado-Tirado S, Amarnani D, Zhao G, Rossin EJ, Eliott D, Miller JB, et al. Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy. Sci Rep. 2020."
    },
    {
      "DOI": "10.1096/fj.202001668R",
      "doi-asserted-by": "crossref",
      "key": "531_CR143",
      "unstructured": "Whitmore HAB, Amarnani D, O’Hare M, Delgado-Tirado S, Gonzalez-Buendia L, An M, et al. TNF-α signaling regulates RUNX1 function in endothelial cells. FASEB J. 2021."
    },
    {
      "DOI": "10.1016/j.ajpath.2020.12.005",
      "author": "L Gonzalez-Buendia",
      "doi-asserted-by": "crossref",
      "first-page": "418",
      "issue": "3",
      "journal-title": "Am J Pathol",
      "key": "531_CR144",
      "unstructured": "Gonzalez-Buendia L, Delgado-Tirado S, An M, O’Hare M, Amarnani D, Whitmore HAB, et al. Treatment of experimental choroidal neovascularization via RUNX1 inhibition. Am J Pathol. 2021;191(3):418–24.",
      "volume": "191",
      "year": "2021"
    },
    {
      "DOI": "10.1136/bmjdrc-2020-001898",
      "doi-asserted-by": "crossref",
      "key": "531_CR145",
      "unstructured": "Xing X, Wang H, Niu T, Jiang Y, Shi X, Liu K. RUNX1 can mediate the glucose and O-GlcNAc-driven proliferation and migration of human retinal microvascular endothelial cells. BMJ Open Diabetes Res Care. 2021;9(1)."
    },
    {
      "DOI": "10.1038/s41467-020-20713-z",
      "author": "M Li",
      "doi-asserted-by": "crossref",
      "first-page": "420",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "531_CR146",
      "unstructured": "Li M, Huang H, Li L, He C, Zhu L, Guo H, et al. Core transcription regulatory circuitry orchestrates corneal epithelial homeostasis. Nat Commun. 2021;12(1):420.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1167/iovs.13-11791",
      "doi-asserted-by": "crossref",
      "key": "531_CR147",
      "unstructured": "Voronov D, Gromova A, Liu D, Zoukhri D, Medvinsky A, Meech R, et al. Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration. Invest Ophthalmol Vis Sci. 2013. Available from: www.iovs.org."
    },
    {
      "DOI": "10.1007/BF02982059",
      "doi-asserted-by": "crossref",
      "key": "531_CR148",
      "unstructured": "Suda T, Takakura N. RoLe of hematopoietic stem cells in angiogenesis. Int J Hematol. 2001;74(3)."
    },
    {
      "DOI": "10.1242/dev.129.8.2015",
      "doi-asserted-by": "crossref",
      "key": "531_CR149",
      "unstructured": "Kalev-Zylinska ML, Horsfield JA, Flores MVC, Postlethwait JH, Vitas MR, Baas AM, et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX-1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development. 2002."
    },
    {
      "DOI": "10.1007/s12253-019-00694-1",
      "doi-asserted-by": "crossref",
      "key": "531_CR150",
      "unstructured": "Liu C, Xu D, Xue B, Liu B, Li J, Huang J. Upregulation of RUNX1 Suppresses proliferation and migration through repressing VEGFA expression in hepatocellular carcinoma. Pathol Oncol Res. 2020;26(2)."
    },
    {
      "DOI": "10.1038/sj.onc.1208287",
      "doi-asserted-by": "crossref",
      "key": "531_CR151",
      "unstructured": "Iwatsuki K, Tanaka K, Kaneko T, Kazama R, Okamoto S, Nakayama Y, et al. Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene. 2005;24(7)."
    },
    {
      "DOI": "10.3390/children10020341",
      "doi-asserted-by": "crossref",
      "key": "531_CR152",
      "unstructured": "Sun E, Kraus CL. The ophthalmic manifestations of Down syndrome. Children. MDPI; 2023."
    },
    {
      "DOI": "10.1177/25158414221101718",
      "author": "A Haseeb",
      "doi-asserted-by": "crossref",
      "first-page": "251584142211017",
      "journal-title": "Ther Adv Ophthalmol",
      "key": "531_CR153",
      "unstructured": "Haseeb A, Huynh E, ElSheikh RH, ElHawary AS, Scelfo C, Ledoux DM, et al. Down syndrome: a review of ocular manifestations. Ther Adv Ophthalmol. 2022;14:251584142211017.",
      "volume": "14",
      "year": "2022"
    },
    {
      "key": "531_CR154",
      "unstructured": "Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singapore Med J. 2006;47(1)."
    },
    {
      "key": "531_CR155",
      "unstructured": "Adio AO, Wajuihian SO. Ophthalmic manifestations of children with Down syndrome in Port Harcourt, Nigeria. Clinical Ophthalmol. 2012;6(1)."
    },
    {
      "DOI": "10.1001/archopht.1973.01000040271001",
      "author": "EJ Williams",
      "doi-asserted-by": "publisher",
      "journal-title": "Arch Ophthalmol",
      "key": "531_CR156",
      "unstructured": "Williams EJ, McCormick AQ, Tischler B. Retinal vessels in Down’s syndrome. Arch Ophthalmol. 1973. https://doi.org/10.1001/archopht.1973.01000040271001.",
      "year": "1973"
    },
    {
      "DOI": "10.1097/00006324-197908000-00005",
      "author": "MC Sherk",
      "doi-asserted-by": "publisher",
      "journal-title": "Optomet Vis Sci",
      "key": "531_CR157",
      "unstructured": "Sherk MC, Williams TD. Disc vascularity in down’s syndrome. Optomet Vis Sci. 1979. https://doi.org/10.1097/00006324-197908000-00005.",
      "year": "1979"
    },
    {
      "DOI": "10.1136/bjo.2007.124248",
      "author": "CF Parsa",
      "doi-asserted-by": "publisher",
      "journal-title": "British J Ophthalmol",
      "key": "531_CR158",
      "unstructured": "Parsa CF, Almer Z. Supranumerary optic disc vessels may indicate reduced systemic angiogenesis in Down syndrome. British J Ophthalmol. 2008. https://doi.org/10.1136/bjo.2007.124248.",
      "year": "2008"
    },
    {
      "DOI": "10.3928/01913913-20121214-01",
      "author": "AJ Schneier",
      "doi-asserted-by": "publisher",
      "journal-title": "J Pediatric Ophthalmol Strabismus",
      "key": "531_CR159",
      "unstructured": "Schneier AJ, Heidary G, Ledoux DM. Optic nerve appearance in patients with down syndrome. J Pediatric Ophthalmol Strabismus. 2013. https://doi.org/10.3928/01913913-20121214-01.",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fneur.2019.00633",
      "author": "L Postolache",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Neurol",
      "key": "531_CR160",
      "unstructured": "Postolache L. Abnormalities of the optic nerve in down syndrome and associations with visual acuity. Front Neurol. 2019. https://doi.org/10.3389/fneur.2019.00633.",
      "year": "2019"
    },
    {
      "DOI": "10.1076/opge.20.1.45.2297",
      "author": "AI Al-Hemidan",
      "doi-asserted-by": "publisher",
      "journal-title": "Ophthalmic Genet",
      "key": "531_CR161",
      "unstructured": "Al-Hemidan AI, Al-Hazzaa SAF, Chavis P, Al-Hussein H. Optic disc elevation in Down syndrome. Ophthalmic Genet. 1999. https://doi.org/10.1076/opge.20.1.45.2297.",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0002-9394(14)76933-8",
      "author": "RA Catalano",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Ophthalmol",
      "key": "531_CR162",
      "unstructured": "Catalano RA, Simon JW. Optic disk elevation in Down’s syndrome. Am J Ophthalmol. 1990. https://doi.org/10.1016/S0002-9394(14)76933-8.",
      "year": "1990"
    },
    {
      "DOI": "10.1155/2020/9726261",
      "author": "A Ugurlu",
      "doi-asserted-by": "publisher",
      "journal-title": "J Ophthalmol",
      "key": "531_CR163",
      "unstructured": "Ugurlu A, Altinkurt E. Ophthalmologic manifestations and retinal findings in children with Down syndrome. J Ophthalmol. 2020. https://doi.org/10.1155/2020/9726261.",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41433-022-02047-w",
      "author": "D Landau Prat",
      "doi-asserted-by": "publisher",
      "journal-title": "Eye",
      "key": "531_CR164",
      "unstructured": "Landau Prat D, Tadros S, Revere KE, Katowitz JA, Katowitz WR. Management of congenital nasolacrimal duct obstruction in down syndrome. Eye. 2022. https://doi.org/10.1038/s41433-022-02047-w.",
      "year": "2022"
    },
    {
      "DOI": "10.1186/s12886-021-01948-w",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Ophthalmol",
      "key": "531_CR165",
      "unstructured": "Li Y, Wei M, Liu X, Zhang L, Song X, Xiao C. Dacryoendoscopy-assisted incision of Hasner’s valve under nasoendoscopy for membranous congenital nasolacrimal duct obstruction after probing failure: a retrospective study. BMC Ophthalmol. 2021. https://doi.org/10.1186/s12886-021-01948-w.",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.jaapos.2004.06.013",
      "author": "CS Lim",
      "doi-asserted-by": "publisher",
      "journal-title": "J AAPOS",
      "key": "531_CR166",
      "unstructured": "Lim CS, Martin F, Beckenham T, Cumming RG. Nasolacrimal duct obstruction in children: outcome of intubation. J AAPOS. 2004. https://doi.org/10.1016/j.jaapos.2004.06.013.",
      "year": "2004"
    },
    {
      "DOI": "10.1210/me.2005-0512",
      "author": "M Jo",
      "doi-asserted-by": "crossref",
      "first-page": "2156",
      "issue": "9",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR167",
      "unstructured": "Jo M, Curry TE. Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles. Mol Endocrinol. 2006;20(9):2156–72.",
      "volume": "20",
      "year": "2006"
    },
    {
      "DOI": "10.1210/en.2008-1527",
      "author": "J Liu",
      "doi-asserted-by": "crossref",
      "first-page": "3291",
      "issue": "7",
      "journal-title": "Endocrinology",
      "key": "531_CR168",
      "unstructured": "Liu J, Park ES, Jo M. Runt-related transcription factor 1 regulates luteinized hormone-induced prostaglandin-endoperoxide synthase 2 expression in rat periovulatory granulosa cells. Endocrinology. 2009;150(7):3291–300.",
      "volume": "150",
      "year": "2009"
    },
    {
      "DOI": "10.1210/me.2009-0325",
      "author": "J Liu",
      "doi-asserted-by": "crossref",
      "first-page": "1203",
      "issue": "6",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR169",
      "unstructured": "Liu J, Park ES, Curry TE, Jo M. Periovulatory expression of hyaluronan and proteoglycan link protein 1 (Hapln1) in the rat ovary: hormonal regulation and potential function. Mol Endocrinol. 2010;24(6):1203–17.",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.yexcr.2015.01.010",
      "author": "F Naillat",
      "doi-asserted-by": "publisher",
      "journal-title": "Exp Cell Res",
      "key": "531_CR170",
      "unstructured": "Naillat F, Yan W, Karjalainen R, Liakhovitskaia A, Samoylenko A, Xu Q, et al. Identification of the genes regulated by Wnt-4, a critical signal for commitment of the ovary. Exp Cell Res. 2015. https://doi.org/10.1016/j.yexcr.2015.01.010.",
      "year": "2015"
    },
    {
      "DOI": "10.1210/en.2004-0407",
      "doi-asserted-by": "crossref",
      "key": "531_CR171",
      "unstructured": "Jo M, Gieske MC, Payne CE, Wheeler-Price SE, Gieske JB, Ignatius I V., et al. Development and application of a rat ovarian gene expression database. Endocrinology. 2004;145(11)."
    },
    {
      "DOI": "10.1210/me.2009-0392",
      "author": "ES Park",
      "doi-asserted-by": "crossref",
      "first-page": "846",
      "issue": "4",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR172",
      "unstructured": "Park ES, Lind AK, Dahm-Kähler P, Brännström M, Carletti MZ, Christenson LK, et al. RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries. Mol Endocrinol. 2010;24(4):846–58.",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1210/me.2005-0420",
      "author": "I Hernandez-Gonzalez",
      "doi-asserted-by": "crossref",
      "first-page": "1300",
      "issue": "6",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR173",
      "unstructured": "Hernandez-Gonzalez I, Gonzalez-Robayna I, Shimada M, Wayne CM, Ochsner SA, White L, et al. Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process? Mol Endocrinol. 2006;20(6):1300–21.",
      "volume": "20",
      "year": "2006"
    },
    {
      "DOI": "10.1038/s41467-019-13060-1",
      "author": "B Nicol",
      "doi-asserted-by": "crossref",
      "first-page": "5116",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "531_CR174",
      "unstructured": "Nicol B, Grimm SA, Chalmel F, Lecluze E, Pannetier M, Pailhoux E, et al. RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2. Nat Commun. 2019;10(1):5116.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.3390/ijms232214442",
      "author": "K Bridges",
      "doi-asserted-by": "crossref",
      "first-page": "14442",
      "issue": "22",
      "journal-title": "Int J Mol Sci",
      "key": "531_CR175",
      "unstructured": "Bridges K, Yao HHC, Nicol B. Loss of Runx1 induces granulosa cell defects and development of ovarian tumors in the mouse. Int J Mol Sci. 2022;23(22):14442.",
      "volume": "23",
      "year": "2022"
    },
    {
      "DOI": "10.1101/2021.06.17.448908",
      "doi-asserted-by": "crossref",
      "key": "531_CR176",
      "unstructured": "Dinh D, Breen J, Nicol B, Smith K, Nicholls M, Emery A, et al. Progesterone receptor-A isoform interaction with RUNX transcription factors controls chromatin remodelling at promoters during ovulation. bioRxiv. 2021."
    },
    {
      "DOI": "10.1210/me.2015-1312",
      "author": "K Wilson",
      "doi-asserted-by": "crossref",
      "first-page": "733",
      "issue": "7",
      "journal-title": "Mol Endocrinol",
      "key": "531_CR177",
      "unstructured": "Wilson K, Park J, Curry TE, Mishra B, Gossen J, Taniuchi I, et al. Core binding factor-β knockdown alters ovarian gene expression and function in the mouse. Mol Endocrinol. 2016;30(7):733–47.",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1210/en.2018-00011",
      "author": "S Lee-Thacker",
      "doi-asserted-by": "crossref",
      "first-page": "2094",
      "issue": "5",
      "journal-title": "Endocrinology",
      "key": "531_CR178",
      "unstructured": "Lee-Thacker S, Choi Y, Taniuchi I, Takarada T, Yoneda Y, Ko CM, et al. Core binding factor b expression in ovarian granulosa cells is essential for female fertility. Endocrinology. 2018;159(5):2094–109.",
      "volume": "159",
      "year": "2018"
    },
    {
      "DOI": "10.1101/2023.03.21.532831",
      "doi-asserted-by": "publisher",
      "key": "531_CR179",
      "unstructured": "Kannan A, Beal JR, Neff AM, Bagchi MK, Bagchi IC. Runx1 regulates critical factors that control uterine angiogenesis and trophoblast differentiation during placental development. Available from: https://doi.org/10.1101/2023.03.21.532831."
    },
    {
      "DOI": "10.1111/j.1651-2227.1978.tb17815.x",
      "author": "B Højager",
      "doi-asserted-by": "crossref",
      "first-page": "637",
      "issue": "5",
      "journal-title": "Acta Paediatr",
      "key": "531_CR180",
      "unstructured": "Højager B, Peters H, Byskov AG, Faber M. Follicular development in ovaries of children with Down’s syndrome. Acta Paediatr. 1978;67(5):637–43.",
      "volume": "67",
      "year": "1978"
    },
    {
      "DOI": "10.1002/ajmg.1320270223",
      "author": "YHH Hsiang",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Med Genet",
      "key": "531_CR181",
      "unstructured": "Hsiang YHH, Berkovitz GD, Bland GL, Migeon CJ, Warren AC. Gonadal function in patients with Down syndrome. Am J Med Genet. 1987. https://doi.org/10.1002/ajmg.1320270223.",
      "year": "1987"
    },
    {
      "DOI": "10.3109/09513599609097904",
      "author": "RM Cento",
      "doi-asserted-by": "publisher",
      "journal-title": "Gynecol Endocrinol",
      "key": "531_CR182",
      "unstructured": "Cento RM, Ragusa L, Proto C, Alberti A, Romano C, Boemi G, et al. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol Endocrinol. 1996. https://doi.org/10.3109/09513599609097904.",
      "year": "1996"
    },
    {
      "DOI": "10.1093/humrep/12.8.1709",
      "author": "RM Cento",
      "doi-asserted-by": "publisher",
      "journal-title": "Human Reprod",
      "key": "531_CR183",
      "unstructured": "Cento RM, Ragusa L, Proto C, Alberti A, Fiore G, Colabucci F, et al. Ovarian sensitivity to follicle stimulating hormone is blunted in normo-ovulatory women with Down’s syndrome. Human Reprod. 1997. https://doi.org/10.1093/humrep/12.8.1709.",
      "year": "1997"
    },
    {
      "DOI": "10.1080/gye.15.1.81.88",
      "author": "RM Cento",
      "doi-asserted-by": "publisher",
      "journal-title": "Gynecol Endocrinol",
      "key": "531_CR184",
      "unstructured": "Cento RM, Proto C, Guido M, Lanzone A. Postmenarchal Down’s syndrome: a theoretical model of growth hormone action on ovarian function. Gynecol Endocrinol. 2001. https://doi.org/10.1080/gye.15.1.81.88.",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0020-7292(99)00123-X",
      "author": "N Angelopoulou",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "issue": "1",
      "journal-title": "Int J Gynecol Obstet",
      "key": "531_CR185",
      "unstructured": "Angelopoulou N, Souftas V, Sakadamis A, Matziari C, Papameletiou V, Mandroukas K. Gonadal function in young women with Down syndrome. Int J Gynecol Obstet. 1999;67(1):15–21.",
      "volume": "67",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s10815-019-01457-2",
      "author": "E Parizot",
      "doi-asserted-by": "publisher",
      "journal-title": "J Assisted Reprod Genet",
      "key": "531_CR186",
      "unstructured": "Parizot E, Dard R, Janel N, Vialard F. Down syndrome and infertility: what support should we provide? J Assisted Reprod Genet. 2019. https://doi.org/10.1007/s10815-019-01457-2.",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10815-005-4878-6",
      "author": "AK Bartmann",
      "doi-asserted-by": "publisher",
      "journal-title": "J Assist Reprod Genet",
      "key": "531_CR187",
      "unstructured": "Bartmann AK, Araújo FM, Iannetta O, Paneto JCC, Martelli L, Ramos ES. Down syndrome and precocious menopause. J Assist Reprod Genet. 2005. https://doi.org/10.1007/s10815-005-4878-6.",
      "year": "2005"
    },
    {
      "DOI": "10.1046/j.1365-2788.1997.03838.x",
      "author": "N Schupf",
      "doi-asserted-by": "publisher",
      "journal-title": "J Intell Disabil Res",
      "key": "531_CR188",
      "unstructured": "Schupf N, Zigman W, Kapell D, Lee JH, Kline J, Levin B. Early menopause in women with Down’s syndrome. J Intell Disabil Res. 1997. https://doi.org/10.1046/j.1365-2788.1997.03838.x.",
      "year": "1997"
    },
    {
      "DOI": "10.3390/cells8101277",
      "author": "S Kaur",
      "doi-asserted-by": "publisher",
      "journal-title": "Cells",
      "key": "531_CR189",
      "unstructured": "Kaur S, Rawal P, Siddiqui H, Rohilla S, Sharma S, Tripathi DM, et al. Increased expression of RUNX1 in liver correlates with NASH activity score in patients with non-alcoholic steatohepatitis (NASH). Cells. 2019. https://doi.org/10.3390/cells8101277.",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41598-019-39112-6",
      "author": "AB Marcher",
      "doi-asserted-by": "publisher",
      "journal-title": "Sci Rep",
      "key": "531_CR190",
      "unstructured": "Marcher AB, Bendixen SM, Terkelsen MK, Hohmann SS, Hansen MH, Larsen BD, et al. Transcriptional regulation of Hepatic stellate cell activation in NASH. Sci Rep. 2019. https://doi.org/10.1038/s41598-019-39112-6.",
      "year": "2019"
    },
    {
      "DOI": "10.3390/ijms22105239",
      "doi-asserted-by": "crossref",
      "key": "531_CR191",
      "unstructured": "Bertran L, Pastor A, Portillo-Carrasquer M, Binetti J, Aguilar C, Martínez S, et al. The potential protective role of runx1 in nonalcoholic fatty liver disease. Int J Mol Sci. 2021;22(10)."
    },
    {
      "DOI": "10.3390/biomedicines10061315",
      "doi-asserted-by": "crossref",
      "key": "531_CR192",
      "unstructured": "Bertran L, Eigbefoh‐addeh A, Portillo‐carrasquer M, Barrientos‐riosalido A, Binetti J, Aguilar C, et al. Identification of the potential molecular mechanisms linking RUNX1 activity with nonalcoholic fatty liver disease, by means of systems biology. Biomedicines. 2022;10(6)."
    },
    {
      "DOI": "10.1074/jbc.M311804200",
      "author": "M Bertrand-Philippe",
      "doi-asserted-by": "crossref",
      "first-page": "24530",
      "issue": "23",
      "journal-title": "J Biol Chem",
      "key": "531_CR193",
      "unstructured": "Bertrand-Philippe M, Ruddell RG, Arthur MJP, Thomas J, Mungalsingh N, Mann DA. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2. J Biol Chem. 2004;279(23):24530–9.",
      "volume": "279",
      "year": "2004"
    },
    {
      "DOI": "10.1053/jhep.2002.35625",
      "doi-asserted-by": "crossref",
      "key": "531_CR194",
      "unstructured": "Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. 2002;36(4)."
    },
    {
      "DOI": "10.1053/jhep.2000.20521",
      "author": "H Yoshiji",
      "doi-asserted-by": "crossref",
      "first-page": "1248",
      "issue": "6",
      "journal-title": "Hepatology",
      "key": "531_CR195",
      "unstructured": "Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, et al. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology. 2000;32(6):1248–54.",
      "volume": "32",
      "year": "2000"
    },
    {
      "DOI": "10.1111/iep.12474",
      "author": "Z Guo",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Exp Path.",
      "key": "531_CR196",
      "unstructured": "Guo Z, Liu X, Zhao S, Sun F, Ren W, Ma M, et al. Original article RUNX1 promotes liver fibrosis progression through regulating TGF-β signalling. Int J Exp Path. 2023. https://doi.org/10.1111/iep.12474.",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.jpeds.2017.07.011",
      "doi-asserted-by": "publisher",
      "key": "531_CR197",
      "unstructured": "De Matteo A, Vajro P. Down syndrome and pediatric nonalcoholic fatty liver disease: a causal or casual relationship? 2017. Available from: https://doi.org/10.1016/j.jpeds.2017.07.011."
    },
    {
      "DOI": "10.1007/s12185-013-1487-5",
      "author": "MJ Park",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Hematol",
      "key": "531_CR198",
      "unstructured": "Park MJ, Sotomatsu M, Ohki K, Arai K, Maruyama K, Kobayashi T, et al. Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis. Int J Hematol. 2014. https://doi.org/10.1007/s12185-013-1487-5.",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jpeds.2012.04.037",
      "author": "H Arnell",
      "doi-asserted-by": "publisher",
      "journal-title": "J Pediatr",
      "key": "531_CR199",
      "unstructured": "Arnell H, Fischler B. Population-based study of incidence and clinical outcome of neonatal cholestasis in patients with down syndrome. J Pediatr. 2012. https://doi.org/10.1016/j.jpeds.2012.04.037.",
      "year": "2012"
    },
    {
      "DOI": "10.1023/A:1018800826608",
      "author": "P Vajro",
      "doi-asserted-by": "publisher",
      "journal-title": "Dig Dis Sci",
      "key": "531_CR200",
      "unstructured": "Vajro P, Cucchiara S, Vegnente A, Iorio R, De Silva C, Cipolletta L, et al. Primary sclerosing cholangitis preceding Crohn’s disease in a child with Down’s syndrome. Dig Dis Sci. 1998. https://doi.org/10.1023/A:1018800826608.",
      "year": "1998"
    },
    {
      "DOI": "10.1097/00005176-200408000-00012",
      "author": "HA Taşdemir",
      "doi-asserted-by": "crossref",
      "first-page": "187",
      "issue": "2",
      "journal-title": "J Pediatr Gastroenterol Nutr",
      "key": "531_CR201",
      "unstructured": "Taşdemir HA, Çetinkaya MC, Polat C, Belet U, Kalayci AG, Akbaş S. Gallbladder motility in children with Down syndrome. J Pediatr Gastroenterol Nutr. 2004;39(2):187–91.",
      "volume": "39",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.celrep.2020.108407",
      "author": "KD Tuttle",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Rep",
      "key": "531_CR202",
      "unstructured": "Tuttle KD, Waugh KA, Araya P, Minter R, Orlicky DJ, Ludwig M, et al. JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of Down syndrome. Cell Rep. 2020. https://doi.org/10.1016/j.celrep.2020.108407.",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.jpeds.2017.05.077",
      "author": "D Valentini",
      "doi-asserted-by": "publisher",
      "journal-title": "J Pediatr",
      "key": "531_CR203",
      "unstructured": "Valentini D, Alisi A, Di Camillo C, Sartorelli MR, Crudele A, Bartuli A, et al. Nonalcoholic fatty liver disease in italian children with Down syndrome: prevalence and correlation with obesity-related features. J Pediatr. 2017. https://doi.org/10.1016/j.jpeds.2017.05.077.",
      "year": "2017"
    },
    {
      "author": "EC Roosen-Runge",
      "first-page": "79",
      "issue": "1",
      "journal-title": "Am J Pathol",
      "key": "531_CR204",
      "unstructured": "Roosen-Runge EC. Fatty infiltration of the liver in patients with mongolism and in children with hydrocephaly and microcephaly. Am J Pathol. 1947;23(1):79.",
      "volume": "23",
      "year": "1947"
    },
    {
      "DOI": "10.1007/BF02233876",
      "author": "LB Seeff",
      "doi-asserted-by": "crossref",
      "first-page": "1102",
      "journal-title": "Am J Dig Dis",
      "key": "531_CR205",
      "unstructured": "Seeff LB, Levitsky J, Tillman PW, Perou ML, Zimmerman HJ. Histopathology of the liver in Down’s syndrome. Am J Dig Dis. 1967;12:1102–13.",
      "volume": "12",
      "year": "1967"
    },
    {
      "DOI": "10.1016/j.numecd.2020.05.012",
      "author": "D Valentini",
      "doi-asserted-by": "crossref",
      "first-page": "1564",
      "issue": "9",
      "journal-title": "Nutr Metab Cardiovasc Dis",
      "key": "531_CR206",
      "unstructured": "Valentini D, Mosca A, Di Camillo C, Crudele A, Sartorelli MR, Scoppola V, et al. PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome. Nutr Metab Cardiovasc Dis. 2020;30(9):1564–72.",
      "volume": "30",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.mod.2006.08.002",
      "author": "E Raveh",
      "doi-asserted-by": "crossref",
      "first-page": "842",
      "issue": "11",
      "journal-title": "Mech Dev",
      "key": "531_CR207",
      "unstructured": "Raveh E, Cohen S, Levanon D, Negreanu V, Groner Y, Gat U. Dynamic expression of Runx1 in skin affects hair structure. Mech Dev. 2006;123(11):842–50.",
      "volume": "123",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jdermsci.2005.12.012",
      "author": "T Soma",
      "doi-asserted-by": "crossref",
      "first-page": "221",
      "issue": "3",
      "journal-title": "J Dermatol Sci",
      "key": "531_CR208",
      "unstructured": "Soma T, Ishimatsu-Tsuji Y, Tajima M, Kishimoto J. Runx1 transcription factor is involved in the regulation of KAP5 gene expression in human hair follicles. J Dermatol Sci. 2006;41(3):221–4.",
      "volume": "41",
      "year": "2006"
    },
    {
      "DOI": "10.1242/dev.012799",
      "author": "KM Osorio",
      "doi-asserted-by": "crossref",
      "first-page": "1059",
      "issue": "6",
      "journal-title": "Development",
      "key": "531_CR209",
      "unstructured": "Osorio KM, Lee SE, McDermitt DJ, Waghmare SK, Zhang YV, Woo HN, et al. Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation. Development. 2008;135(6):1059–68.",
      "volume": "135",
      "year": "2008"
    },
    {
      "DOI": "10.1128/MCB.01308-09",
      "author": "CSL Hoi",
      "doi-asserted-by": "crossref",
      "first-page": "2518",
      "issue": "10",
      "journal-title": "Mol Cell Biol",
      "key": "531_CR210",
      "unstructured": "Hoi CSL, Lee SE, Lu SY, McDermitt DJ, Osorio KM, Piskun CM, et al. Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol Cell Biol. 2010;30(10):2518–36.",
      "volume": "30",
      "year": "2010"
    },
    {
      "DOI": "10.1083/jcb.201006068",
      "author": "KM Osorio",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "issue": "1",
      "journal-title": "J Cell Biol",
      "key": "531_CR211",
      "unstructured": "Osorio KM, Lilja KC, Tumbar T. Runx1 modulates adult hair follicle stem cell emergence and maintenance from distinct embryonic skin compartments. J Cell Biol. 2011;193(1):235–50.",
      "volume": "193",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1213015110",
      "author": "J Lee",
      "doi-asserted-by": "crossref",
      "first-page": "4634",
      "issue": "12",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "531_CR212",
      "unstructured": "Lee J, Hoi CSL, Lilja KC, White BS, Lee SE, Shalloway D, et al. Runx1 and p21 synergistically limit the extent of hair follicle stem cell quiescence in vivo. Proc Natl Acad Sci U S A. 2013;110(12):4634–9.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.celrep.2013.12.039",
      "author": "SE Lee",
      "doi-asserted-by": "crossref",
      "first-page": "499",
      "issue": "3",
      "journal-title": "Cell Rep",
      "key": "531_CR213",
      "unstructured": "Lee SE, Sada A, Zhang M, McDermitt DJ, Lu SY, Kemphues KJ, et al. High Runx1 levels promote a reversible, more-differentiated cell state in hair-follicle stem cells during quiescence. Cell Rep. 2014;6(3):499–513.",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.7554/eLife.45977",
      "author": "KN Li",
      "doi-asserted-by": "publisher",
      "journal-title": "Elife",
      "key": "531_CR214",
      "unstructured": "Li KN, Jain P, He CH, Eun FC, Kang S, Tumbar T. Skin vasculature and hair follicle cross-talking associated with stem cell activation and tissue homeostasis. Elife. 2019. https://doi.org/10.7554/eLife.45977.",
      "year": "2019"
    },
    {
      "DOI": "10.1111/pde.14731",
      "author": "C Ryan",
      "doi-asserted-by": "publisher",
      "journal-title": "Pediatric Dermatol",
      "key": "531_CR215",
      "unstructured": "Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatric Dermatol. 2021. https://doi.org/10.1111/pde.14731.",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.jaad.2023.03.026",
      "doi-asserted-by": "crossref",
      "key": "531_CR216",
      "unstructured": "Kranyak A, Rork J, Levy J, Burdick TE. Alopecia areata and thyroid screening in Down syndrome: leveraging epic cosmos dataset. J Am Acad Dermatol. 2023; Available from: http://www.ncbi.nlm.nih.gov/pubmed/36997068."
    },
    {
      "DOI": "10.1034/j.1399-0039.2002.600604.x",
      "author": "R Tazi-Ahnini",
      "doi-asserted-by": "publisher",
      "journal-title": "Tissue Antigens",
      "key": "531_CR217",
      "unstructured": "Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJG, et al. Role of the autoimmune regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens. 2002. https://doi.org/10.1034/j.1399-0039.2002.600604.x.",
      "year": "2002"
    },
    {
      "DOI": "10.3389/fimmu.2022.955035",
      "author": "M Lensing",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Immunol",
      "key": "531_CR218",
      "unstructured": "Lensing M, Jabbari A. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.955035.",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.jdcr.2019.02.007",
      "author": "AL Rachubinski",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "issue": "4",
      "journal-title": "JAAD Case Rep",
      "key": "531_CR219",
      "unstructured": "Rachubinski AL, Estrada BE, Norris D, Dunnick CA, Boldrick JC, Espinosa JM. Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata. JAAD Case Rep. 2019;5(4):365–7.",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1002/eji.201948451",
      "author": "MJD Baars",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "issue": "2",
      "journal-title": "Eur J Immunol",
      "key": "531_CR220",
      "unstructured": "Baars MJD, Douma T, Simeonov DR, Myers DR, Kulhanek K, Banerjee S, et al. Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity. Eur J Immunol. 2021;51(2):471–82.",
      "volume": "51",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12985-022-01764-8",
      "author": "Y Hu",
      "doi-asserted-by": "publisher",
      "journal-title": "Virol J",
      "key": "531_CR221",
      "unstructured": "Hu Y, Pan Q, Zhou K, Ling Y, Wang H, Li Y. RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling. Virol J. 2022. https://doi.org/10.1186/s12985-022-01764-8.",
      "year": "2022"
    },
    {
      "DOI": "10.1101/2023.01.27.525911",
      "doi-asserted-by": "publisher",
      "key": "531_CR222",
      "unstructured": "Zezulin AU, Ye D, Howell E, Yen D, Bresciani E, Diemer J, et al. RUNX1 is required in granulocyte-monocyte progenitors to attenuate inflammatory cytokine production by neutrophils. Available from: https://doi.org/10.1101/2023.01.27.525911."
    },
    {
      "DOI": "10.1152/ajplung.00348.2010",
      "author": "KJ Haley",
      "doi-asserted-by": "publisher",
      "first-page": "L693",
      "issue": "5",
      "journal-title": "Am J Physiol-Lung Cell Mol Physiol",
      "key": "531_CR223",
      "unstructured": "Haley KJ, Lasky-Su J, Manoli SE, Smith LA, Shahsafaei A, Weiss ST, Tantisira K. RUNX transcription factors: association with pediatric asthma and modulated by maternal smoking. Am J Physiol-Lung Cell Mol Physiol. 2011;301(5):L693–701. https://doi.org/10.1152/ajplung.00348.2010.",
      "volume": "301",
      "year": "2011"
    },
    {
      "DOI": "10.1165/rcmb.2016-0319OC",
      "author": "X Tang",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "issue": "2",
      "journal-title": "Am J Respir Cell Mol Biol",
      "key": "531_CR224",
      "unstructured": "Tang X, Sun L, Jin X, Chen Y, Zhu H, Liang Y, et al. Runt-related transcription factor 1 regulates LPS-induced acute lung injury via NF-kB signaling. Am J Respir Cell Mol Biol. 2017;57(2):174–83.",
      "volume": "57",
      "year": "2017"
    },
    {
      "DOI": "10.1093/cvr/cvx161",
      "author": "OD Liang",
      "doi-asserted-by": "crossref",
      "first-page": "1560",
      "issue": "13",
      "journal-title": "Cardiovasc Res",
      "key": "531_CR225",
      "unstructured": "Liang OD, So EY, Egan PC, Goldberg LR, Aliotta JM, Wu KQ, et al. Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension. Cardiovasc Res. 2017;113(13):1560–73.",
      "volume": "113",
      "year": "2017"
    },
    {
      "DOI": "10.1093/cvr/cvac001",
      "author": "EM Jeong",
      "doi-asserted-by": "crossref",
      "first-page": "3211",
      "issue": "16",
      "journal-title": "Cardiovasc Res",
      "key": "531_CR226",
      "unstructured": "Jeong EM, Pereira M, So EY, Wu KQ, Del Tatto M, Wen S, et al. Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension. Cardiovasc Res. 2022;118(16):3211–24.",
      "volume": "118",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s40119-021-00251-5",
      "author": "DS Bush",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "issue": "1",
      "journal-title": "Cardiol Therapy",
      "key": "531_CR227",
      "unstructured": "Bush DS, Dunbar Ivy D. Pulmonary hypertension in the population with Down syndrome. Cardiol Therapy. 2022;11(1):33–47. https://doi.org/10.1007/s40119-021-00251-5.",
      "volume": "11",
      "year": "2022"
    },
    {
      "DOI": "10.1007/978-981-10-3233-2_28",
      "author": "DCC Voon",
      "doi-asserted-by": "publisher",
      "first-page": "471",
      "key": "531_CR228",
      "unstructured": "Voon DCC, Thiery JP. The emerging roles of RUNX transcription factors in epithelial-mesenchymal transition. In: Groner Y, Ito Y, Liu P, Neil JC, Speck NA, van Wijnen A, editors. RUNX Proteins in Development and Cancer. Singapore: Springer; 2017. p. 471–89. https://doi.org/10.1007/978-981-10-3233-2_28.",
      "volume-title": "RUNX Proteins in Development and Cancer",
      "year": "2017"
    },
    {
      "author": "AS Samarakkody",
      "first-page": "99",
      "issue": "2",
      "journal-title": "Mol Cells",
      "key": "531_CR229",
      "unstructured": "Samarakkody AS, Shin NY, Cantor AB. Role of RUNX family transcription factors in DNA damage response. Mol Cells. 2020;43(2):99–106.",
      "volume": "43",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41467-018-03451-1",
      "author": "X Hou",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "531_CR230",
      "unstructured": "Hou X, Zhang Y, Li W, Hu AJ, Luo C, Zhou W, Hu JK, Daniele SG, Wang J, Sheng J, Fan Y, Greenberg AS, Farmer SR, Hu MG. CDK6 inhibits white to beige fat transition by suppressing RUNX1. Nat Commun. 2018. https://doi.org/10.1038/s41467-018-03451-1.",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.bbcan.2022.188715",
      "author": "TC Lin",
      "doi-asserted-by": "publisher",
      "first-page": "188715",
      "issue": "3",
      "journal-title": "Biochimica et Biophysica Acta (BBA) Rev Cancer",
      "key": "531_CR231",
      "unstructured": "Lin TC. RUNX1 and cancer. Biochimica et Biophysica Acta (BBA) Rev Cancer. 2022;1877(3):188715. https://doi.org/10.1016/j.bbcan.2022.188715.",
      "volume": "1877",
      "year": "2022"
    }
  ],
  "reference-count": 231,
  "references-count": 231,
  "relation": {
    "references": [
      {
        "asserted-by": "subject",
        "id": "",
        "id-type": "uri"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00531-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}